Notably, considering the observed overexpression of WRNIP1 in the most common human cancer types, such as lung and breast cancers, our discoveries contribute to a deeper understanding of mechanisms cells employ to counteract TRCs. The gene discussed is WRNIP1; the disease is breast carcinoma.